Journal of Neurology Neurosurgery and Psychiatry

Article	Citations
#3080 A systematic review of extra-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis	110
133 Multiple sclerosis and the risk of infection: a consensus guideline	93
090 Frequency of migraine and the use of preventive medication in a UK primary care population	84
West is best – a strongman with numb feet	79
053 Brainshuttle AD: Investigating safety, tolerability, and PK/PD of RG6102 in prodromal/mild-to-moderate AD	77
117 Who is the culprit – the virus or the anti-virus?	76
102 Levodopa and melanoma what do clinicians think?	74
194 CANVAS-related sensory ganglionopathy without severe ataxia – the importance of muscle afferents in proprioception	72
134 Predictors of serum vitamin D level in multiple sclerosis	70
072 Fenfluramine directly inhibits cortical spreading depolarisation: a patho physiologic process linked to SUDEP	69
192 Tacrolimus-induced chronic inflammatory demyelinating polyradiculoneuropa- thy (CIDP): a case series	67
193 Unusual presentation of hereditary neuropathy with liability to pressure palsies (HNPP)	67
086 Long-term efficacy of fremanezumab in migraine patients with inadequate response to prior preventive medication classes	62
092 Brain amylin accumulation in Parkinson’s disease is not driven by type 2 diabetes mellitus	60
033 Extracranial-tumor cerebri	60
018 A retrospective analysis of shunts for idiopathic intracranial hypertension: a 10-year experience at St. George’s University Hospital	58
Parallel Session 1: Muscle, nerve and quality| Wed 18 May, 1115 – 1230|04 Project NeuroSafe: safety practice in neurology services	57
205 Relationship between thrombin generation and micro-embolic signals in moderate-severe asymptomatic and symptomatic carotid stenosis patients	57
Cryptic confusion	55
109 Embedding patient voice in trial design: the EJS ACT-PD experience	55
122 A case of posterior reversible encephalopathy syndrome: a rheumatologic conundrum	54
061 The long-term effects of anterior temporal lobe resection on memory encoding: A longitudinal fMRI study	54
059 Cannabidiol in refractory adult epilepsies: broadening the Lennox-Gastaut phenotype?	52
Idiopathic intracranial hypertension: evaluation of births and fertility through the hospital episode statistic dataset 2002–2020	52
089 Re-admission rate for patients with headache in Southwest London – can this be addressed?	52

079 Does the timing of IIH diagnosis in relation to pregnancy affect outcomes?	51
084 Migraine and sociodemographic factors a review	51
139 Characterising DARC (Detecting Apoptosing Retinal Cells) spots in optic neuritis	51
074 No valvular heart disease or pulmonary artery hypertension with fenfluramine for up to 3 years	50
160 Ophthalmological involvement in m.3243A>G-related mitochondrial disease	49
129 Multiple sclerosis relapse patterns in a population-based cohort	48
163 Immunosuppression guidelines ongoing implementation project	46
091 The East London Parkinson’s disease project – engaging a diverse population in research	46
175 A case series of anti-HMGCR immune mediated necrotizing myopathy: the West Midlands data	45
Call for emergency action to limit global temperature increases, restore biodiversity and protect health	45
#3115 Systematic review into the effects of sleep disorders on the development of PTSD	45
#3113 Evaluating the PCL-C as a measure of trauma and PTSD symptoms in patients with functional neurological symptom disorder	43
Long-term maintenance of mycophenolate mofetil in anti-NMDA receptor encephalitis (LEARN): a multicentre, open-label, blinded-endpoint, randomised controlled trial	43
Impact of fish consumption on disability progression in multiple sclerosis	43
Cavernomas: a randomised effectiveness (CARE) trial: treatment with versus without neurosurgery for symptomatic brain cavernoma	42
256  FIREFISH part 2: risdiplam efficacy and safety in type 1 SMA	41
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)	41
046 Sporadic Creutzfeldt-Jakob disease in the young: a 10 year review of United Kingdom national surveillance	40
Bariatric surgery versus community weight management intervention for idiopathic intracranial hypertension: a randomised controlled trial	40
UK Multiple Sclerosis service audit of 70 centres: access to neuroradiology	39
087  Paramagnetic rims are a specific biomarker in multiple sclerosis	39
003  Neuroanatomical signatures of genetic risk for Alzheimer’s disease in healthy adults	39
Neural correlates of memory deficits in premanifestC9orf72-repeat expansions	38
109  UK multiple sclerosis service audit of 70 centres: observed staffing, proposed staffing, coping	38
114  Effect of siponimod on cognitive processing speed in SPMS patients with active and non-active disease	38
113  Benefit-risk of ofatumumab in treatment-naïve early relapsing multiple sclerosis patients	38
Immersive medical virtual reality: still a novelty or already a necessity?	37
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum diso	37
232  Organisational impact of upcoming Huntington’s disease treatments in Europe: resource gaps, access to care	36
238  Cogniton and mood disorder in cervical dystonia	36
184  Right data, right care	36
A localisation issue	36
125  Complex cortical visual impairments following bilateral occipital infarcts after traumatic brain injury	35
243  Mood disorder affects age at onset of adult-onset cervical dystonia	35
Bad altitude	35
180  Outcomes of new referrals to neurology clinics with unexplained symptoms: observational study of 208 patients	35
154  Crossed cerebellar diaschisis in refractory epilepsy	34
080  Listen to learn: podcast-series for IMT induction at National Hospital for Neurology and Neurosurgery	33
075  Secondary syphilis presenting as acute unilateral visual loss in an immunocompetent elderly patient	33
021  Tics in patients with encephalitis	33
072  The oblique path of a transverse lesion	32
L-arginine and mitochondrial encephalomyopathy, lactic acidosis and stroke- like episodes (MELAS): a systematic review	32
188  Structural differences in access to neurological healthcare in Northern Ireland: a neurodisparity index	32
228  Testing shortened versions of smell tests to screen for hyposmia in Parkinson’s disease	32
201  Management of an unusual presentation of spontaneous intracranial hypotension (SIH)	32
016  Long-term efficacy and safety of perampanel in elderly patients from phase III open-label extension studies	32
019  Reduced activations within right mesial temporal lobe for visual episodic memory in right temporal lobe epilepsy	31
028  Cladribine to halt deterioration in people with advanced multiple sclerosis (ChariotMS)	31
128  White matter fibre loss in Parkinson’s disease hallucinations	31
001  Machine learning accurately determines the population prevalence of Alzheimer’s disease based on microbiome profile	31

203  Outcomes of patients with discordant CSF bilirubin and oxyhaemoglobin xanthochromia Results a retrospective audit	31
Review of the clinical spectrum of typical and atypical Lyme neuroborreliosis in southwest England	30
119  Long-term effectiveness of natalizumab for RRMS: UK and global interim results from TYSABRI observational program	30
020  Long-term efficacy of ocrelizumab in relapsing multiple sclerosis: 6 study years	29
When the rhythm moves you	29
166  A not-to-be-missed mimic of TB meningitis	29
005  Infusion associated reactions in ocrelizumab-treated multiple sclerosis patients	29
106  Inflammatory peripheral neuropathy in haematological malignancies	29
146  Epilepsy, deprivation and mortality in Wales 2005–2017	29
Parkinson’s disease determinants, prediction and gene-environment interac- tions: a UK Biobank study	28
158  Non-epilpetic attack disorder admission in the Royal Preston Hospital	28
041  Posterior reversible encephalopathy syndrome (PRES) in mild and severe COVID-19	28
038  Pregnancy outcomes in patients treated with ocrelizumab	27
066  Clinical and imaging findings in MOG antibody positive patients presenting to Kings College Hospital	27
102  The cost of misdiagnosis in POEMS syndrome	27
058  Tolosa-Hunt syndrome with features of trigeminal autonomic cephalagia, pituitary enlargement, and non-lateralised headache	27
#3101 Imbalanced basal ganglia connectivity is associated with motor deficits and apathy in Huntingtons disease: first evidence from human in vivo neuroimaging	26
34 A systematic review comparing symptomaticity and markers of interoception in patients with functional seizures, and dual diagnosis epilepsy with functional seizures	26
Neuroinflammation and protein aggregation co-localize across the spectrum of frontotemporal dementia	26
27 Prevalence of lower urinary tract dysfunction in consecutive patients attending a tertiary referral functional neurological disorders clinic in Edinburgh	26
099  Safety and effectiveness of dimethyl fumarate in multiple sclerosis patients treated over 5 years	26
35 Processing speed (PS) improvement in alcohol related brain damage (ARBD)	25
10 What can we learn from the nervous sequelae of past pandemics?	25
2 Into the gray zone: assessing residual cognitive function after serious brain injury	25
9 Psychopathology & the nature of the Self	25
164  Progressive multifocal leukoencephalopathy (PML) following autologous periph- eral blood stem cell transplantation for multiple myeloma	25
31 Disorganization of language and working memory networks in frontal versus temporal lobe epilepsy	25
3 Medicolegal aspects of neuropsychiatry: malingering	25
063  Improving service provision for patients with suspected idiopathic intracranial hypertension in a joint neuro-ophthalmology clinic	24
017  PROVE study 506: perampanel in real-world clinical care of patients based on seizure type	24
102  Translating logistical challenges into service improvement: MS infusional services during the covid-19 pandemic	24
076  Increased physiological responses to threat in Duchenne muscular dystrophy: a potential CNS outcome measure	24
094  Measuring neutralising antibodies (NAbs) to interferon-beta (IFNB) for multiple sclerosis (MS): a neglected practice?	24
175  Quality improvement: re-structuring the neurology ‘In-hours’ on-call service at North Bristol Trust	23
263  Neurofilament light chain is a predictor of outcome after aneurysmal subarach- noid haemorrhage	23
009  Language decline following white matter tract damage during anterior temporal lobe resection in language dominant hemisphere	23
White matter hyperintensities and brain microbleeds in ataxia-telangiectasia: the Cambridge cohort	23
126  A case report of the emergence of neurosarcoidosis after COVID-19 infection	22
Plasma neurofilament light levels as a novel biomarker for neurological involve- ment in Wilson’s disease	22
143  Catastrophising cognitions in patients with psychogenic non-epileptic seizures compared to patients with epilepsy	22
141  Guillain-Barre as a post-operative syndrome following resection of anaplastic astrocytoma	22
064  Imilimumab/nivolumab induced paraspinal myositis causing dysphagia	22
010  Safety and efficacy of long-term dimethyl fumarate treatment	22
192  Transitioning: how hard can it really be?	22
122  Neurological manifestations of haemophagocytic lymphohistiocytosis	21
095  Remyelination in people with MS due to an RXR agonist is age-dependent	21
119  NeuroToolkit CSF biomarkers track the progression of Alzheimer’s disease at very early stages	21
139  Presentation of a rare dysautonomic variant of Guillain-Barré syndrome	20
Neural (re)organisation of language and memory: implications for neuroplasticity and cognition	20
#3071 Acute escitalopram administration increases premature responding as a function of reward magnitude in healthy male volunteers	20
117  The role of the cerebellum in cortical myoclonus: a neurophysiological study	20
Effectiveness of the Interdisciplinary Home-bAsed Reablement Programme (I-HARP) on improving functional independence of people living with dementia: a multicentre, pragmatic, randomised, open-label, c	20
#3031 Outcome and evaluation of an outpatient multidisciplinary group-based rehabilitative therapy programme for functional neurological disorder	20
101 Motor and non-motor features of prodromal PD	20
Working years lost in people with epilepsy: a population-based cohort study	20
miRNA-214 to predict progression and survival in ALS	20
#3122 Is subjective cognitive decline (SCD) a better marker of susceptibility to functional cognitive disorder (FCD) than to neurodegeneration?: The caerphilly prospective study	19
#3083 Fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): an interoceptive predictive coding model of pain and fatigue expression	19
226  Reduced synaptic density in progressive supranuclear palsy and corticobasal syndrome, revealed by [11C]UCB-J PET	19
15 Attenuated heart-brain integration predicts functional non-epileptic seizures	19
#3121 Adapting the queen square guided self help (QGSH) for functional neurological disorders as a stand-alone intervention: an exonian pilot study	19
#3119 Diagnosis and management of functional neurological symptoms: Saudi Arabia experience	19
Epilepsy-related causes of mortality in people with epilepsy: a systematic review of systematic reviews	19
099  High relapse rate with steroid monotherapy in non-systemic vasculitic neuropathy	18
Clinical-radiological presentation and natural history of iatrogenic cerebral amyloid angiopathy	18
Tract-specific white matter hyperintensities and neuropsychiatric syndromes: a multicentre memory clinic study	18
09 Religiosity and risk of Parkinson’s disease in England and the USA	18
188 SUNFISH 3-year efficacy and safety of risdiplam in types 2 and 3 SMA	18
Greater occipital nerve block modulates nociceptive signals within the trigeminocervical complex	18
#3112 Acquired aphantasia in 88 cases: a preliminary report	18
Clinical feature and disease outcome in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder: a Chinese study	18
24 Self-awareness of deficits following brain injury: implications for mental capacity and recovery	18
IntronicFGF14GAA repeat expansions are a common cause of ataxia syndromes with neuropathy and bilateral vestibulopathy	18
Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence	18
#3118 Tic-severity moderators: a systematic review on the subjectivity of external and internal factors in moderating tic-severity in Tourette’s syndrome	18
Motor context modulates substantia nigra pars reticulata spike activity in patients with Parkinson’s disease	18
202  Placebo-controlled intravenous nitroglycerin phenotyping of acute attacks of cluster headache	18
12 A pilot investigation of interoceptive accuracy, awareness, and sensibility in functional neurological disorder	18
19 Group psychotherapy/guided self help for patients with FNSD awaiting in-patient MDT programme treatment: a pilot study	18
20 Reflexive downregulation of memory systems in dissociative amnesia: a case series	17

A new science of emotion: implications for functional neurological disorder	17
Sodium valproate is associated with cortical thinning of disease-specific areas in juvenile myoclonic epilepsy	17
Revisiting the jumping to conclusions bias in functional movement disorders	17
Frontotemporal dementia and autism spectrum disorder: complex bedfellows	17
22 How does the free cog compare to the Addenbrooke’s cognitive examination (ACE III) in traumatic brain injury (TBI)?	17
One side effect: two networks? Lateral and posteromedial stimulation spreads induce dysarthria in subthalamic deep brain stimulation for Parkinson’s disease	17
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage	17
The psychological scars of Intensive Care	17
091  CIDP mimic in a patient with HIV; An unusual presentation of POEMS syndrome	17
Haemorrhagic myelitis as a manifestation of MOG antibody-associated disease	17
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis	17
Code ICH: reorganising stroke care for intracerebral haemorrhage	16
Cardiovascular risk and obesity impact loss of grey matter volume earlier in males than females	16
Microstructural plasticity in nociceptive pathways after spinal cord injury	16
Novel therapies in CIDP	16
Multiple sclerosis reactivations after fingolimod discontinuation for pregnancy planning	16
Nitrous oxide-induced myeloneuropathy: a case series	16
Effectiveness of conservative non-pharmacological interventions in people with muscular dystrophies: a systematic review and meta-analysis	16
Prevalence and burden of pain across the entire spectrum of Huntington’s disease	16
Blood biomarkers: ready for clinical practice?	16
Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies	16
NICE guideline on ME/CFS: robust advice based on a thorough review of the evidence	16
Prevalence of epilepsy: a population-based cohort study in Denmark with comparison to Global Burden of Disease (GBD) prevalence estimates	16
Early life involvement in C9orf72 repeat expansion carriers	16
GPi-DBS-induced brain metabolic activation in cervical dystonia	16
The influence of epigenetic biological age on key complications and outcomes in aneurysmal subarachnoid haemorrhage	16
Precision medicine for epilepsies: are we there yet?	15
Charcot-Marie-Tooth disease type 2CC due toNEFHvariants causes a progressive, non-length-dependent, motor-predominant phenotype	15
What should we do about vaccination of patients on anti-CD20 antibody therapy?	15
Towards a better recognition of paraneoplastic brainstem encephalitis	15
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination	15
Age-dependent effect of susceptibility factors on the risk of intracerebral haemorrhage: Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy)	15
Lesional psychiatric neurosurgery: meta-analysis of clinical outcomes using a transdiagnostic approach	15
Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis	15
Paraneoplastic cochleovestibulopathy: clinical presentations, oncological and serological associations	15
GBA variants influence cognitive status in amyotrophic lateral sclerosis	15
Epileptic phenotypes in autoimmune encephalitis: from acute symptomatic seizures to autoimmune-associated epilepsy	14
Unravelling the influence of affective stimulation on functional neurological symptoms: a pilot experiment examining potential mechanisms	14
Predictive value of retinal atrophy for cognitive decline across disease duration in multiple sclerosis	14
Characterising ALS disease progression according to El Escorial and Gold Coast criteria	14
Best practices in phase III clinical trials on DMTs for multiple sclerosis: a systematic analysis and appraisal of published trials	14
Direct additive genetics and maternal effect contribute to the risk of Tourette disorder	14
Postural misperception: a biomarker for persistent postural perceptual dizziness	14
Correspondence on functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines	14
Evidence of publication bias in multiple sclerosis clinical trials: a comparative analysis of published and unpublished studies registered in ClinicalTrials.gov	14
Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohort	14
Reliable virtual clinical assessment in spino-bulbar muscular atrophy (SBMA)	14
Cognitive decline and diabetes: a systematic review of the neuropathological correlates accounting for cognition at death	14
Binary reversals: a diagnostic sign in primary progressive aphasia	13
First-trimester use of antiseizure medications and the risk of miscarriage: a population-based cohort study	13
Functional parcellation of the cingulate gyrus by electrical cortical stimulation: a synthetic literature review and future directions	13
Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts	13
Blood biomarkers may distinguish among dementia disorders	13
Diagnosing myasthenia gravis using orthoptic measurements: assessing extraocular muscle fatiguability	13
Improving clinical practice with an old friend from the neuroimmunology toolkit: acute corticosteroids in LGI1 antibody encephalitis	13
Fat-rich versus carbohydrate-rich nutrition in ALS: a randomised controlled study	13
Brain18fluorodeoxyglucose-positron emission tomography changes in amyotrophic lateral sclerosis withTARDBPmutations	13
Exploring the cost-effectiveness of EBV vaccination to prevent multiple sclerosis in an Australian setting	13
Improved naming in patients with Broca’s aphasia with tDCS	13
Stroke outcome of early antiplatelet in post-thrombolysis haemorrhagic infarction	13
Development of a sensitive trial-ready poly(GP) CSF biomarker assay forC9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis	13
Microstructural changes in the normal appearance cerebral cortex of multiple sclerosis detected by an advanced diffusion MRI technique	13
CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkers	12
Younger age at multiple sclerosis onset is associated with worse outcomes at age 50	12
The end of the affair?	12
Spinal cord reserve in multiple sclerosis	12
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy	12
Cerebroprotection in the endovascular era: an update	12
Atrial cardiopathy and non-stenotic intracranial complicated atherosclerotic plaque in patients with embolic stroke of undetermined source	12
Correction: The future of neuroprotection in stroke	12
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders	12
Ipsilateral and axial tremor response to focused ultrasound thalamotomy for essential tremor: clinical outcomes and probabilistic mapping	12
Thymectomy and disease duration in non-thymomatous acetylcholine receptor antibody-positive myasthenia gravis: a single-centre, cross-sectional study	12
In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI	12
Retinal imaging in Alzheimer’s disease	11
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network	11
High frequency ofHTRA1ANDABCC6mutations in Japanese patients with adult-onset cerebral small vessel disease	11
Correction: ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease	11
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis	11
LDL cholesterol is associated with higher AD neuropathology burden independent of APOE	11
Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments	11
ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson’s disease	11
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis	11
Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosis	11
Navigating the presymptomatic frontier in genetic ALS and FTD	11
Pathophysiology, diagnosis and care of Alzheimer’s disease are coming together	11
Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?	11
STN-DBS electrode placement accuracy and motor improvement in Parkinson’s disease: systematic review and individual patient meta-analysis	11
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial	11
De novo mutations in SOD1 are a cause of ALS	11
Psychological well-being trajectories preceding incident mild cognitive impairment and dementia	11
Prognostic significance of peripheral neutrophils and lymphocytes in early untreated Parkinson’s disease: an 8-year follow-up study	11
Deep learning-based personalised outcome prediction after acute ischaemic stroke	11
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60	11
C5 complement inhibition and FcRn modulation in generalized myasthenia gravis. Fast-acting but short-lived therapies the use of which should prompt assertive escalation of conventional treatments	11